US FDA’s OCI Director Is Leaving For Private Practice
Executive Summary
George Karavetsos’ last day is Jan. 20, which coincidentally is the start of the Trump Administration. Office of Criminal Investigations has been subject of recent Congressional scrutiny.
You may also be interested in...
Califf Optimistic As He Departs US FDA
Outgoing commissioner highlights efforts to improve staff, says bucket list mostly accomplished. Agency now faces hiring freeze challenge.
Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post
Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.
US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure
Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.